Pharmacy Groups Applaud Senate Finance Committee’s Bipartisan Effort to Relieve DIR Fees

National pharmacy organizations once again applaud the Senate Finance Committee’s bipartisan effort to relieve DIR fees.  Senate Finance Committee Chair Chuck Grassley, Ranking Member Ron Wyden, and 23 members of the committee (over 80% of the committee) signed a letter send to HHS Secretary Alex Azar and CMS Administrator Seema Verma urging them to to […]

Over 200 Pharmacy Stakeholder Groups Urge Senate Finance to Fix DIR

Over 200 pharmacy stakeholder and patient advocacy groups sent a letter to Senators Chuck Grassley and Ron Wyden, chairman and ranking member of the Senate Finance Committee, urging them to include DIR fee reform in their drug pricing legislation.  NASPA, along with NCPA, APhA, and many state pharmacy associations, signed on to the letter. The […]

DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs

Morning Consult published an opinion piece by NACDS President and CEO Steve Anderson last week entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.” The op-ed emphasizes the threat of DIR (direct and indirect remuneration) fees and lays out the ways in which DIR fee reform will lower patients’ out-of-pocket costs and […]